Our core focus lies in diagnosing and classifying malignancies. With cutting-edge techniques and a deep understanding of cancer biology, we provide precise pathological assessments to support hospitals in tailoring treatment strategies.

From routine biopsies to complex cases, we specialize in analyzing tissue samples at a microscopic level. Our reports empower hospitals to make informed decisions for patient management.

Leveraging advanced IHC protocols, we identify protein markers essential for determining tumor subtypes, prognostic indicators, and targeted therapy options.

Our expertise in analyzing cellular abnormalities via fine-needle aspirates and body fluids ensures early detection of malignancies, aiding early intervention.

We offer critical reassurance to hospitals by reviewing complex or ambiguous cases. Our second-opinion services enhance diagnostic confidence and align treatment pathways.